Skip to main content
Clinical Trials/NL-OMON26974
NL-OMON26974
Recruiting
Not Applicable

Evaluation of genetic, enzymatic, biochemical and clinical characteristics of OCTN2 deficiency to determine if newborn screening is useful and feasible

MC Utrecht0 sites380 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
MC Utrecht
Enrollment
380
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
MC Utrecht

Eligibility Criteria

Inclusion Criteria

  • OCTN2 deficiency, confirmed by reduced carnitine transporter activity in cultured fibroblasts and/or mutations in the SLC22A5 gene.
  • \- Subject referred to academic centre for OCTN2 deficiency because of low carnitine level in NBS.
  • \- Mother analysed in academic centre for OCTN2 deficiency due to low carnitine level in infant’s NBS

Exclusion Criteria

  • No eligible subjects will be excluded from this study

Outcomes

Primary Outcomes

Not specified

Similar Trials